China Resources Boya Bio-pharmaceutical Hits Day Low Amid Price Pressure at CNY 18.40

China Resources Boya Bio-pharmaceutical Group Co., Ltd. experienced a significant decline today, with the stock dropping by 5.43% and reaching an intraday low of CNY 18.40. This performance is notably weaker compared to the China Shanghai Composite, which fell by 3.63% on the same day. Over the past week, the stock has seen a decline of 11.2%, and its one-month performance reflects a drop of 15.78%. Year-to-date, the stock is down 18.27%, and its one-year performance shows a substantial decrease of 32.89%. The three-year performance indicates a decline of 48.38%, while the five-year and ten-year metrics also reveal significant underperformance, with losses of 35.01% and 37.85%, respectively. Financial metrics indicate challenges for the company, including a low Return on Capital Employed (ROCE) of 11.74% and a Return on Equity (ROE) of 3.64%. The company has also faced declining net sales and operating profit over the past five years. Despite these challenges, the stock offers a dividend yield of 1.67%.